Longcor Jarrod 4/A
4/A · Cellectar Biosciences, Inc. · Filed Mar 5, 2020
Insider Transaction Report
Form 4/AAmended
Longcor Jarrod
Chief Operating Officer
Transactions
- Award
Stock option (right to buy)
2020-02-03+40,000→ 40,000 totalExercise: $2.71Exp: 2030-02-03→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]This Form 4/A is being filed to correct a Form 4 filed on February 4, 2020, in which the stock option grant was reported as a common stock grant. The underlying value of the award remains unchanged.
- [F2]Stock options vest in equal annual increments on February 3, 2021, February 3, 2022, and February 3, 2023.